In patients at high ischemic risk implanted with a drug-eluting stent who had 12 months of dual antiplatelet therapy, ...
More than half of healthy adults in Denmark and Spain had silent atherosclerosis detected across three vascular territories ...
Milvexian did not lower risk for CV death, MI or ischemic stroke. No excess bleeding risk was reported. MUNICH — Milvexian ...
Early administration of evolocumab prior to PCI for acute MI significantly improved patients’ chances of meeting ...
The United States’ death rate likely dropped to a record low last year, according to provisional CDC data.The National Center ...
The FDA approved an updated round of COVD-19 vaccines for the 2026-2027 respiratory disease season that target circulating ...
The FDA has approved tirzepatide for reduction of cardiovascular risk in adults with type 2 diabetes, Eli Lilly ...
Discontinuing chronic daily therapies while taking cystic fibrosis triple therapy did not result in greater lung function ...
In March 2020, as COVID-19 surged around the globe, Dolly Parton announced that she was making a $1 million donation to ...
Statin therapy cut risk for major adverse CV events by 30% for healthy older adults compared with placebo, but did not extend disability-free survival, according to data presented at the European ...
E-scooters are popular for recreation and transportation, with ride-share options available in 133 cities across the United ...
In patients with left-sided infective endocarditis, a response-tailored antibiotic strategy conferred more time alive without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results